Paul Rennie

Paul Rennie

Fortuna: 2 M $ al 30/06/2026

Health Technology
Distribution Services

Perfil

Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., where he currently holds the title of Executive Chairman & Managing Director.
Paradigm Biopharmaceuticals Ltd. was founded in 2014.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd. as Non-Executive Chairman, Stiefel Research Australia Pty Ltd. as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd. as Manager-Business Development, Mesoblast Ltd. as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd. as Manager-Sales & Marketing.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/06/2026 21.409.425 ( 3,66 % ) 2 M $ 30/06/2026

Cargos activos de Paul Rennie

EmpresasCargoInicio
PARADIGM BIOPHARMACEUTICALS LIMITED Director Ejecutivo 22/11/2022

Antiguos cargos conocidos de Paul Rennie.

EmpresasCargoFin
NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED Director Ejecutivo 11/09/2023
Corporate Officer/Principal -
MERCK KGAA Ventas & Marketing -
Roche Diagnostics Australia Pty Ltd.
Ventas & Marketing -
MESOBLAST LIMITED Director de Operaciones -
Ver el detalle de la experiencia de Paul Rennie.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

5

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Distribution Services

Health Technology

Health Technology

Roche Diagnostics Australia Pty Ltd.

Health Technology

Health Technology